184 related articles for article (PubMed ID: 19574337)
1. Long-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and calcification markers.
Wang AY; Lam CW; Chan IH; Wang M; Lui SF; Sanderson JE
Nephrol Dial Transplant; 2009 Dec; 24(12):3826-33. PubMed ID: 19574337
[TBL] [Abstract][Full Text] [Related]
2. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
Wang AY; Woo J; Lam CW; Wang M; Chan IH; Gao P; Lui SF; Li PK; Sanderson JE
Nephrol Dial Transplant; 2005 Aug; 20(8):1676-85. PubMed ID: 15899935
[TBL] [Abstract][Full Text] [Related]
3. Increased circulating inflammatory proteins predict a worse prognosis with valvular calcification in end-stage renal disease: a prospective cohort study.
Wang AY; Lam CW; Wang M; Chan IH; Yu CM; Lui SF; Sanderson JE
Am J Nephrol; 2008; 28(4):647-53. PubMed ID: 18292652
[TBL] [Abstract][Full Text] [Related]
4. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
[TBL] [Abstract][Full Text] [Related]
6. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
[TBL] [Abstract][Full Text] [Related]
7. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
[TBL] [Abstract][Full Text] [Related]
8. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
[TBL] [Abstract][Full Text] [Related]
9. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
de Mutsert R; Grootendorst DC; Axelsson J; Boeschoten EW; Krediet RT; Dekker FW;
Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of plasma myeloperoxidase in ESRD patients.
Wang AY; Lam CW; Chan IH; Wang M; Lui SF; Sanderson JE
Am J Kidney Dis; 2010 Nov; 56(5):937-46. PubMed ID: 20638167
[TBL] [Abstract][Full Text] [Related]
11. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.
Stompór T; Pasowicz M; Sulłowicz W; Dembińska-Kieć A; Janda K; Wójcik K; Tracz W; Zdzienicka A; Klimeczek P; Janusz-Grzybowska E
Am J Kidney Dis; 2003 Jan; 41(1):203-11. PubMed ID: 12500238
[TBL] [Abstract][Full Text] [Related]
12. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
14. Elevated cardiac troponin T predicts cardiovascular events in asymptomatic continuous ambulatory peritoneal dialysis patients without a history of cardiovascular disease.
Han SH; Choi HY; Kim DK; Moon SJ; Lee JE; Yoo TH; Kim BS; Kang SW; Choi KH; Lee HY; Han DS
Am J Nephrol; 2009; 29(2):129-35. PubMed ID: 18719346
[TBL] [Abstract][Full Text] [Related]
15. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
[TBL] [Abstract][Full Text] [Related]
16. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
17. Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients.
Metry G; Stenvinkel P; Qureshi AR; Carrero JJ; Yilmaz MI; Bárány P; Snaedal S; Heimbürger O; Lindholm B; Suliman ME
Eur J Clin Invest; 2008 Nov; 38(11):804-11. PubMed ID: 19021697
[TBL] [Abstract][Full Text] [Related]
18. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients.
Terrier N; Jaussent I; Dupuy AM; Morena M; Delcourt C; Chalabi L; Rouanet C; Canaud B; Cristol JP
Nephrol Dial Transplant; 2008 Jan; 23(1):345-53. PubMed ID: 17890748
[TBL] [Abstract][Full Text] [Related]
19. Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis.
Lam MF; Leung JC; Lo WK; Tam S; Chong MC; Lui SL; Tse KC; Chan TM; Lai KN
Nephrol Dial Transplant; 2007 May; 22(5):1445-50. PubMed ID: 17277343
[TBL] [Abstract][Full Text] [Related]
20. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]